skip to content

Investor contacts

Roche investor relations group headquarters

F. Hoffmann-La Roche Ltd.
Investor Relations
CH-4070 Basel
Switzerland

For all general enquiries please call the Roche switchboard on

For IR requests use


Our investor relations team

Bruno Eschli

Head of Investor Relations

+41 61 687 5284

Sabine Borngräber

IR Officer

+41 61 688 8027

Birgit Masjost

IR Officer

+41 61 688 4814

Beatrice Hau

Coordination

+ 41 61 688 9274

Melanie Wolf

Coordination

+41 61 687 8259

Eva Losert

Coordination

+41 61 688 0284

Roche investor relations group North America

Roche Holdings, Inc.
Genentech, Inc.
Investor Relations North America
1 DNA Way
South San Francisco, CA 94080
USA

For all general enquiries please call the Genentech switchboard on

For IR requests use

Your contact person

Loren Kalm

Investor Relations Officer

+1 650-225-3217

Please note that the provided investor contacts on this site are not to be used to report adverse events or to ask any questions regarding medical products.

Reporting side-effects related to our products should be sent to your Roche local safety contact. For country-specific contact details  

Patients are being asked to primarily contact their personal physician

Discover more

Investors
Investors

We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.